Related Experiment Video
Updated: Jul 20, 2026
03:59
Therapeutic Massage for Psychological Well-being in Geriatric Oncology
Published on: May 22, 2026
Mood disorders in the elderly
Mehret Gebretsadik1, Sundeep Jayaprabhu, George T Grossberg
1Department of Psychiatry, Saint Louis University School of Medicine, 1221 South Grand Boulevard, MO 63104, USA.
The Medical Clinics of North America
|September 12, 2006
Summary
Mood disorders in older adults are a significant health concern, often undiagnosed. Early diagnosis and treatment of late-life mood disorders can improve quality of life and save lives.
Area of Science:
- Geriatric Psychiatry
- Mental Health in Older Adults
Background:
- Mood disorders represent a growing cause of illness and death in the elderly population.
- Late-life mood disorders are frequently overlooked and undertreated, leading to adverse outcomes.
Purpose of the Study:
- To highlight the importance of timely diagnosis and treatment for mood disorders in older adults.
- To emphasize the potential for current and future treatments to improve patient outcomes.
Main Methods:
- This study is a review of current understanding and treatment approaches for mood disorders in the elderly.
- Analysis of existing literature on diagnosis and therapeutic interventions for late-life mood disturbances.
Main Results:
- Prompt diagnosis and treatment of mood disorders in older adults can significantly enhance quality of life for patients and their families.
- Effective treatments are available for most older adults experiencing mood disorders.
- Promising future treatments exist, especially for individuals with treatment-resistant depression.
Conclusions:
- Addressing mood disorders in the elderly is crucial for reducing morbidity and mortality.
- Early and appropriate intervention is key to improving outcomes and potentially saving lives in older adults with mood disorders.
- Advances in treatment offer hope for better management, including for complex cases of depression.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...